GLENMEDE TRUST CO NA - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2019$0
-100.0%
3750.0%0.00%
Q2 2019$1,0000.0%3750.0%0.00%
Q1 2019$1,000
-99.2%
375
-95.7%
0.00%
Q3 2018$119,000
+13.3%
8,8230.0%0.00%
Q2 2018$105,000
+81.0%
8,8230.0%0.00%
Q1 2018$58,0000.0%8,8230.0%0.00%
Q4 2017$58,000
-19.4%
8,8230.0%0.00%
Q3 2017$72,000
+50.0%
8,8230.0%0.00%
Q2 2017$48,0000.0%8,8230.0%0.00%
Q1 2017$48,000
+37.1%
8,8230.0%0.00%
Q4 2016$35,000
-50.0%
8,823
-11.8%
0.00%
Q3 2016$70,000
-58.8%
9,998
-52.2%
0.00%
-100.0%
Q2 2016$170,000
+580.0%
20,923
+574.9%
0.00%
Q1 2016$25,000
-32.4%
3,1000.0%0.00%
Q4 2015$37,000
+27.6%
3,100
+24.0%
0.00%
Q3 2015$29,000
-12.1%
2,500
+37.0%
0.00%
Q2 2015$33,0001,8250.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2015
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders